NovaBridge Biosciences: operating_income
| Value | {"amount": -94269000, "concept": "us-gaap:OperatingIncomeLoss", "currency": "USD"} |
|---|---|
| Period | 2025-01-01 – 2025-12-31 |
| Status | current |
| Entity | NovaBridge Biosciences |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T18:00:48.227251+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/d7f1c392-c2b1-45ed-a8bb-e763d689f823
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001778016-26-000002Retrieved: 2026-08-19T18:00:48.227251+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001778016/operating-income/2025-12-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/d7f1c392-c2b1-45ed-a8bb-e763d689f823
History
- no predecessors — first report